Summary
The inhibition of alkaline phosphatase by insulin is a finding reported by many researchers but the mechanism of this inhibition has not been studied. Since alkaline phosphatase is an important factor in the mechanism of calcification and an impairment of mineralisation has been observed in diabetes mellitus, a study was carried out to assess the effect of the hormone on alkaline phosphatase measured in chondrocytes, in matrix vesicles and in a purified enzyme preparation. Enzyme activity was inhibited by insulin. The lowest active concentration was 10−6 M and maximal inhibition was obtained at about 10−4 M. The inhibition is of the uncompetitive type. Full recovery of the hormone-inhibited enzyme was obtained with 10−4 M 2-mercaptoethanol. Data suggest direct interaction between the alkaline phosphatase and insulin molecules, involving either disulfide cross linkages or the metal chelating activity of insulin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ali S. Y., Saidera S. W., Anderson H. C.: Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage — Proc. nat. Acad. Sci. (Wash.)67, 1513, 1970.
Baici A.: The specific velocity plot — Europ. J. Biochem.119, 9, 1981.
Bonucci E.: Matrix vesicles: their role in calcification. In:Linde A. (Ed.): Dentin and Dentinogenesis. CRC Press Inc., Boca Raton/FL, 1984, vol. 1, p. 135.
Bradford M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding — Anal. Biochem.72, 248, 1976.
Catalan R. E., Martinez A. M., Aragones M. D., Miguel B. G., Robles A.: Insulin action on brain microvessels: effects on alkaline phosphatase — Biochem. biophys. Res. Commun.150, 583, 1988.
Corvol M. T., Dumontier M. F., Rappaport R., Guyda H., Posner B. I.: The effect of a slightly acidic somatomedin peptide (ILAs) on the sulphation of proteoglycans from articular and growth plate chondrocytes in culture — Acta endocrinol. (Kbh.)89, 263, 1978.
De Bernard B., Bianco P., Bonucci E., Costantini M., Lunazzi G. C., Martinuzzi P., Modricky C., Moro L., Panfili E., Pollesello P., Stagni N., Vittur F.: Biochemical and immunohistochemical evidence that in cartilage and alkaline phosphatase is a Ca2+-binding glycoprotein — J. Cell Biol.103, 1615, 1986.
Dixon M.: The graphical determination of Km and Ki — Biochem. J.129, 197, 1972.
Eisenthal R., Cornish-Bowden: A new graphical procedure for estimating enzyme kinetic parameters — Biochem. J.139, 715, 1974.
Fernley H. N.: Mammalian alkaline phosphatases. In:Boyer P. D. (Ed.): The Enzymes. Academic Press, New York-London, 1971; vol. 4, p. 417.
Hui S. L., Epstein S., Johnston C. C. Jr. A prospective study of bone mass in patients with type I diabetes — J. clin. Endocrinol.60, 74, 1985.
Levin M. E., Boisseau V. C., Avioli L. V.: Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes — New Engl. J. Med.294, 241, 1976.
Levy J. R., Murray E., Manolagas S., Olefsky J. M.: Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells — Endocrinology119, 1786, 1986.
Lineweaver H., Burk D.: The determination of enzyme dissociation constants — J. Amer. chem. Soc.56, 658, 1934.
McNair P., Madsbad S., Christiansen C., Christensen M. S., Faber O. K., Binder C., Transbøl I.: Development of bone mineral loss in insulin-treated diabetics: a one-and-a-half year follow-up study in sixty patients — Europ. J. clin. Invest.11, 55, 1981.
Miki A., Tanaka Y., Ogata S., Ikehara Y.: Selective preparation and characterisation of membranous and soluble forms of alkaline phosphatase from rat tissues — Europ. J. Biochem.160, 41, 1986.
Santiago J. V., McAlister W. H., Rabzan S. K., Bussman Y., Haymond M. V., Shackelford G., Weldon V. V.: Decreased cortical thickness and osteopenia in children with diabetes mellitus — J. clin. Endocrinol. Metabol.45, 845, 1977.
Shore R. M., Chesney R., Mazzes R. B., Rose P. G., Bargman G. J.: Osteopenia in juvenile diabetes — Calcif. Tissue Int.33, 455, 1981.
Weiss J. M., Henthorn P. S., Lafferty M. A., Slaughter C., Raducha M., Harris H.: Isolation and characterisation of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase — Biochemistry (Wash.)83, 7182, 1986.
Wiske P. S., Wentworth S. M., Norton J. A. Jr., Epstein S., Johnston C. C. Jr.: Evaluation of bone mass and growth in young diabetics — Metabolism31, 848, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gazzarrini, C., Stagni, N., Pollesello, P. et al. Possible mechanism of inhibition of cartilage alkaline phosphatase by insulin. Acta diabet. lat 26, 321–327 (1989). https://doi.org/10.1007/BF02624644
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624644